Shares of Lifecore Biomedical, Inc. LFCR took a nosedive during Wednesday’s trading session upon the company’s strategic evaluation process’ conclusion, marked by management succession and board changes.
In response, Lifecore Biomedical shares dwindled by a significant 31.7% to $4.91 on Wednesday.
Here’s a look at the other stocks on the move during Wednesday’s mid-day session.
Potential Winners
- ETAO International Co., Ltd. ETAO witnessed a staggering surge of 111.5% to $0.3025 after announcing a reverse stock split.
- XTL Biopharmaceuticals Ltd. XTLB rose by an impressive 74.3% to $1.7950 following plans to acquire The Social Proxy.
- TruGolf Holdings, Inc. TRUG experienced a notable 56% climb to $1.7938 after announcing an expanded AI technology licensing agreement with mlSpatial.
- Treasure Global Inc. TGL saw a surge of 39% to $6.09.
- Anghami Inc. ANGH rallied 37% to $1.3703.
- Oblong, Inc. OBLG rose by a notable 30.7% to $0.1765 after issuing a financial report for the fourth quarter of 2023.
- SCWorx Corp. WORX surged by 27% to $3.6061 after a remarkable 54% climb on the previous day.
- Edgio, Inc. EGIO gained 26% to $8.79.
- Annovis Bio, Inc. ANVS exhibited a 25.6% increase to $11.21 following updates on its Phase 2/3 study of Buntanetap in patients with Alzheimer’s disease.
- Taysha Gene Therapies, Inc. TSHA rose by 23% to $2.7650 after posting favorable FY23 EPS results.
- Cemtrex, Inc. CETX jumped 22% to $4.31.
- Swvl Holdings Corp. SWVL saw a notable 19.7% rise to $10.16.
- Brenmiller Energy Ltd BNRG climbed 19% to $2.94.
- CareMax, Inc. CMAX experienced an 18.4% rise to $5.80.
- Digital World Acquisition Corp. DWAC gained 18.1% to $43.00.
- TeraWulf Inc. WULF jumped 18% to $2.0297 amidst a Bitcoin uptick.
- Blade Air Mobility, Inc. BLDE rose by 17.1% to $2.87 post a $20 million share buyback announcement.
- Canopy Growth Corporation CGC saw a 15% rise to $4.4056 after a call from VP Kamala Harris to reschedule marijuana by the DEA.
- Pagaya Technologies Ltd. PGY surged by 12.4% to $10.25.
- Iris Energy Limited IREN rose by 11.3% to $5.00.
- Sportradar Group AG SRAD climbed by 10.7% to $11.17 post a strong fourth-quarter performance and a $200 million shares buyback.
- BYND Cannasoft Enterprises Inc. BCAN surged by 10% to $0.0220 following a 15% drop the previous day.
- The Beauty Health Company SKIN gained 9.3% to $4.3050.
- Marathon Digital Holdings, Inc. MARA jumped 7.5% to $20.77 amidst a Bitcoin price increase.
- Spirit AeroSystems Holdings, Inc. SPR rose by 6.7% to $35.19.
Underperformers
- NuScale Power Corporation SMR stocks plummeted by 28% to $4.73 after a recent downgrade and price target adjustment by Wells Fargo.
- Ontrak, Inc. OTRK fell by 26% to $0.3258 following a substantial surge the day before.
- Momentus Inc. MNTS dropped 21.7% to $0.4647 post US patent news.
- Aterian, Inc. ATER lost 21.3% to $0.26 after announcing a reverse stock split.
Market Downturn: Shares Plummet Significantly Across Various Sectors
- Aquestive Therapeutics (NASDAQ: AQST) witnessed a sharp decline of 15.4% to $4.51 following the pricing of its $75 million underwritten public offering of 16,666,667 common shares at $4.50 per share.
- Aptorum Group Limited (NYSE: APM) saw a notable drop of 14.8% to $8.20.
- Airship AI Holdings, Inc. (NASDAQ: AISP) also faced a decline of 14.8% to $10.88.
- Seelos Therapeutics, Inc. (NASDAQ: SEEL) dipped 14.6% to $0.5550 after the company revealed that its ALS study with SLS-005 did not achieve statistical significance in the primary and secondary endpoints.
- Astria Therapeutics, Inc. (NASDAQ: ATXS) registered a fall of 13.3% to $14.47.
- Signet Jewelers Limited (NYSE: SIG) tumbled 11% to $91.20 after reporting weaker-than-anticipated fourth-quarter sales and providing a lackluster FY25 outlook.
- Mercurity Fintech Holding Inc. (NYSE: MFH) experienced a decrease of 10.7% to $1.41.
- Harrow, Inc. (NASDAQ: HROW) witnessed an 8.6% drop to $9.73 following disappointing fourth-quarter results.
- Sotera Health Company (NASDAQ: SHC) declined 8.8% to $11.96.
- Adverum Biotechnologies, Inc. (NASDAQ: ADVM) saw a 7.8% decrease to $1.52.
- BioNTech SE (NASDAQ: BNTX) fell 6.3% to $88.24 post reporting weaker-than-expected fourth-quarter FY23 earnings and issuing FY2024 guidance.